Harbor Capital Advisors, Inc. Kura Oncology, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 38,790 shares of KURA stock, worth $705,202. This represents 0.06% of its overall portfolio holdings.
Number of Shares
38,790
Previous 30,891
25.57%
Holding current value
$705,202
Previous $659,000
21.24%
% of portfolio
0.06%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$129 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$127 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$106 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$98.4 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$82.5 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.22B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...